Aminoquinoline–Rhodium (II) Conjugates as Src-Family SH3 Ligands

SC Martin, ZT Ball - ACS Medicinal Chemistry Letters, 2019 - ACS Publications
SC Martin, ZT Ball
ACS Medicinal Chemistry Letters, 2019ACS Publications
High-affinity, selective ligands are sought for a variety of biomolecules but are particularly
difficult to generate in the protein–protein interaction space. Rhodium (II) conjugates provide
a structure-based approach to improved affinity and specificity for targeting protein–protein
interactions such as SH3 domains. In this study of small-molecule–rhodium conjugates, we
report a potent ligand 4b (K d of 27 nM) for the Lyn SH3 domain, based on an
aminoquinoline fragment. The results demonstrate robust affinity gains possible from even …
High-affinity, selective ligands are sought for a variety of biomolecules but are particularly difficult to generate in the protein–protein interaction space. Rhodium(II) conjugates provide a structure-based approach to improved affinity and specificity for targeting protein–protein interactions such as SH3 domains. In this study of small-molecule–rhodium conjugates, we report a potent ligand 4b (Kd of 27 nM) for the Lyn SH3 domain, based on an aminoquinoline fragment. The results demonstrate robust affinity gains possible from even modest small-molecule leads through cooperative inorganic–organic binding, based on specific histidine interactions. A docking study sheds light on the structural basis of binding and supports a previously proposed binding model.
ACS Publications